Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Upgrades Surf Air Mobility Inc (SRFM) to Buy
-
Circle Files Registration Statement for Proposed Initial Public Offering
-
White Mountains Partners Announces Acquisition Of Enterprise Solutions (WTM)
-
WHITE MOUNTAINS PARTNERS ANNOUNCES ACQUISITION OF ENTERPRISE SOLUTIONS
-
Euro Manganese Announces Upsize to Previously Announced Financing of up to C$11.2m (A$12.3m) including a Private Placement with Eric Sprott
-
Ackroo Completes Sale to Paystone
-
Cantor to acquire Canaccord Genuity Group's U.S.-based Global Wholesale Market Making Business
-
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 31 03 2025] - (CGWL)
-
Form 8.3 - [ALLIANCE PHARMA PLC - 31 03 2025] - (CGWL)
-
Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025
-
Canaccord Genuity Reiterates Hold Rating on Vertex (VRTX)
-
Canaccord Genuity Reiterates Buy Rating on Bioventus Inc (BVS)
-
ESS Inc. (GWH) PT Lowered to $3 at Canaccord Genuity
-
Canaccord Genuity Upgrades Future PLC (FUTR:LN) to Hold
-
Sprott Physical Platinum and Palladium Trust Updates Its “At-The-Market” Equity Program
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 28 03 2025] - (CGWL)
-
DeFi Technologies Inc. Announces Record 2024 Financial Results: Adjusted Revenues of C$204.4 million (US$144.8 million), Adjusted EBITDA of $116.1 million (US$80.4 million) and Adjusted Net Income of
-
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
-
Canaccord Genuity Starts Medallion Metals Ltd (MM8:AU) at Spec. Buy
-
Canaccord Genuity Starts LGI Limited (LGI:AU) at Buy
-
Marvel Biosciences Announces Private Placement
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - Opening Disclosure - 27 03 2025] - (CGAML)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 27 03 2025] - (CGWL)
-
2024 Full Year Financial Results
-
Significant Increase in Nalunaq Mineral Resource Estimate
-
Rupert Resources Closes $51.75 Million Bought Deal Equity Financing
-
Canaccord Genuity Reiterates Buy Rating on Beachbody Company (BODI)
-
Canaccord Genuity Reiterates Buy Rating on MP Materials (MP)
-
Worthington Industries (WOR) PT Raised to $54 at Canaccord Genuity
-
NamSys Announces Normal Course Issuer Bid
-
Cornish Metals closes fundraising tranche and appoints Board member
-
Cornish Metals Closes Final Tranche of Fundraising and Appoints Mr. James Whiteside to the Board of Directors
-
MRF 2025 Resource Limited Partnership Final Closing April 29, 2025
-
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
-
Thor Explorations Announces Release of Fact-Finding Committee Report on Osun State Dispute
-
GFL Environmental Inc. Announces Direct Share Buyback of 17,050,298 Subordinate Voting Shares from BC Partners and Intention to Repurchase up to 7,056,027 Subordinate Voting Shares in Secondary Offeri
-
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
-
Canaccord Genuity Reiterates Buy Rating on Verve Therapeutics (VERV)
-
Canaccord Genuity Reiterates Buy Rating on Holley (HLLY)
-
Intuitive Machines Inc. (LUNR) PT Lowered to $21 at Canaccord Genuity
-
Dragonfly Energy Corp. (DFLI) PT Raised to $3 at Canaccord Genuity
-
Middlefield Canadian Income PCC - Annual Financial Report
-
Valeura Energy Inc. Announces Another Year of Record Results in 2024
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA), 'estimate 1Q25 deliveries are mostly being impacted by supply constraints'
-
eToro Group (ETOR) Files Registration Statement for Proposed Initial Public Offering
-
eToro Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Canaccord Genuity Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
-
Strategy (MSTR) acquired approximately 6,911 more bitcoins

